Percentage of cases discussed at Local/state Oncology Information a MDT meeting for which Systems treatment plans are developed by the MDT Percentage of patients screened Local health service/hospital data, e.g. Psychosocial for psychosocial distress multidisciplinary team meeting records, care patient records Percentage of patients who were Hospital clinical registers Clinical enrolled in a clinical Percentage of clinical trials with nil recruitment Percentage of clinical trials closed early due to low recruitment Percentage of patients who have a Local health service/hospital data, e.g. Survivorship survivorship plan multidisciplinary team meeting records, patient records Percentage of patients who health service/hospital data, e.g. End-of-life and received chemotherapy during last multidisciplinary team meeting records, palliative month of life patient records care Percentage of patients with an advanced care directive Table . Across all Priority Questions (qualitative data) Reporting Possible high-level indicators Data source options to consider element Extent to which jurisdiction is able to Description of data available and Variation use available data to identify areas how it has been used across the of variation in align with Optimal Jurisdictional records pathway Cancer Care Pathways, e.g. variation by cancer type, point in cancer pathway, geographic region, patient socioeconomic or other factors Resources associated with adopting Map and description of resource Resource Optimal Cancer Care Pathways implications of Any resource savings associated Jurisdictional records with adopting Optimal Cancer Care adopting Stakeholder consultations Pathways Optimal Cancer Care Pathways
Percentage of cases discussed at a MDT meeting for which treatment plans are developed by the MDT Local/state Oncology Information Systems Psychosocial care Percentage of patients screened for psychosocial distress Local health service/hospital data, e.g. multidisciplinary team meeting records, patient records Clinical Percentage of patients who were enrolled in a clinical Percentage of clinical trials with nil recruitment Percentage of clinical trials closed early due to low recruitment Hospital clinical registers Survivorship Percentage of patients who have a survivorship plan Local health service/hospital data, e.g. multidisciplinary team meeting records, patient records End-of-life and palliative care Percentage of patients who received chemotherapy during last month of life Percentage of patients with an advanced care directive health service/hospital data, e.g. multidisciplinary team meeting records, patient records Table . Across all Priority Questions (qualitative data) Reporting element Possible high-level indicators Data source options to consider Variation across the pathway Extent to which jurisdiction is able to use available data to identify areas of variation in align with Optimal Cancer Care Pathways, e.g. variation by cancer type, point in cancer pathway, geographic region, patient socioeconomic or other factors Description of data available and how it has been used Jurisdictional records Resource of adopting Optimal Cancer Care Pathways Resources associated with adopting Optimal Cancer Care Pathways Any resource savings associated with adopting Optimal Cancer Care Pathways Map and description of resource implications Jurisdictional records Stakeholder consultations
Data%20Guidance%20Tables.docx